Insurance - Property & Casualty
Compare Stocks
5 / 10Stock Comparison
LMND vs ROOT vs HIPO vs OSCR vs VERX
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Property & Casualty
Insurance - Specialty
Medical - Healthcare Plans
Software - Application
LMND vs ROOT vs HIPO vs OSCR vs VERX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Property & Casualty | Insurance - Property & Casualty | Insurance - Specialty | Medical - Healthcare Plans | Software - Application |
| Market Cap | $4.18B | $798M | $714M | $5.41B | $2.34B |
| Revenue (TTM) | $821M | $1.56B | $480M | $13.30B | $768M |
| Net Income (TTM) | $-139M | $56M | $113M | $-39M | $-6M |
| Gross Margin | 47.6% | 17.9% | 40.5% | 17.4% | 63.3% |
| Operating Margin | -16.3% | 4.1% | 24.2% | 0.1% | -1.1% |
| Forward P/E | — | 29.0x | 114.3x | 34.7x | 19.9x |
| Total Debt | $182M | $201M | $52M | $430M | $360M |
| Cash & Equiv. | $385M | $690M | $250M | $2.77B | $314M |
LMND vs ROOT vs HIPO vs OSCR vs VERX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Lemonade, Inc. (LMND) | 100 | 58.4 | -41.6% |
| Root, Inc. (ROOT) | 100 | 24.8 | -75.2% |
| Hippo Holdings Inc. (HIPO) | 100 | 11.0 | -89.0% |
| Oscar Health, Inc. (OSCR) | 100 | 77.6 | -22.4% |
| Vertex, Inc. (VERX) | 100 | 66.7 | -33.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LMND vs ROOT vs HIPO vs OSCR vs VERX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LMND has the current edge in this matchup, primarily because of its strength in long-term compounding.
- -21.6% 10Y total return vs VERX's -38.7%
- 40.2% revenue growth vs VERX's 12.2%
- +78.2% vs VERX's -60.8%
ROOT is the clearest fit if your priority is growth exposure.
- Rev growth 29.0%, EPS growth 22.4%, 3Y rev CAGR 69.6%
HIPO is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 1.40, Low D/E 12.0%, current ratio 0.35x
- 23.4% margin vs LMND's -16.9%
- 6.0% ROA vs LMND's -7.4%, ROIC 22.8% vs -36.8%
Among these 5 stocks, OSCR doesn't own a clear edge in any measured category.
VERX ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 0 yrs, beta 0.83
- Beta 0.83, current ratio 0.98x
- Lower P/E (19.9x vs 34.7x)
- Beta 0.83 vs LMND's 2.75
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.2% revenue growth vs VERX's 12.2% | |
| Value | Lower P/E (19.9x vs 34.7x) | |
| Quality / Margins | 23.4% margin vs LMND's -16.9% | |
| Stability / Safety | Beta 0.83 vs LMND's 2.75 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +78.2% vs VERX's -60.8% | |
| Efficiency (ROA) | 6.0% ROA vs LMND's -7.4%, ROIC 22.8% vs -36.8% |
LMND vs ROOT vs HIPO vs OSCR vs VERX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
LMND vs ROOT vs HIPO vs OSCR vs VERX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROOT leads in 1 of 6 categories
HIPO leads 1 • LMND leads 0 • OSCR leads 0 • VERX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — HIPO and OSCR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OSCR is the larger business by revenue, generating $13.3B annually — 27.7x HIPO's $480M. HIPO is the more profitable business, keeping 23.4% of every revenue dollar as net income compared to LMND's -16.9%. On growth, LMND holds the edge at +55.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $821M | $1.6B | $480M | $13.3B | $768M |
| EBITDAEarnings before interest/tax | -$121M | $73M | $116M | $40M | $50M |
| Net IncomeAfter-tax profit | -$139M | $56M | $113M | -$39M | -$6M |
| Free Cash FlowCash after capex | $20M | $181M | $50M | $2.8B | $99M |
| Gross MarginGross profit ÷ Revenue | +47.6% | +17.9% | +40.5% | +17.4% | +63.3% |
| Operating MarginEBIT ÷ Revenue | -16.3% | +4.1% | +24.2% | +0.1% | -1.1% |
| Net MarginNet income ÷ Revenue | -16.9% | +3.6% | +23.4% | -0.3% | -0.8% |
| FCF MarginFCF ÷ Revenue | +2.4% | +11.6% | +10.4% | +21.0% | +12.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +55.0% | +12.6% | +10.2% | +52.6% | +11.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +45.3% | +95.3% | +114.1% | +125.0% | -128.6% |
Valuation Metrics
ROOT leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 12.4x trailing earnings, HIPO trades at a 97% valuation discount to VERX's 366.8x P/E. On an enterprise value basis, ROOT's 5.9x EV/EBITDA is more attractive than VERX's 26.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.2B | $798M | $714M | $5.4B | $2.3B |
| Enterprise ValueMkt cap + debt − cash | $4.0B | $309M | $517M | $3.1B | $2.4B |
| Trailing P/EPrice ÷ TTM EPS | -23.67x | 25.41x | 12.36x | -12.35x | 366.75x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.04x | 114.33x | 34.65x | 19.90x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 5.88x | 8.16x | — | 26.77x |
| Price / SalesMarket cap ÷ Revenue | 5.67x | 0.53x | 1.52x | 0.46x | 3.13x |
| Price / BookPrice ÷ Book value/share | 7.33x | 2.47x | 1.64x | 5.58x | 10.21x |
| Price / FCFMarket cap ÷ FCF | — | 4.15x | 78.49x | 5.11x | 33.76x |
Profitability & Efficiency
HIPO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HIPO delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-27 for LMND. HIPO carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to VERX's 1.39x. On the Piotroski fundamental quality scale (0–9), ROOT scores 6/9 vs OSCR's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -26.5% | +15.4% | +27.4% | -3.3% | -2.5% |
| ROA (TTM)Return on assets | -7.4% | +3.7% | +6.0% | -0.6% | -0.5% |
| ROICReturn on invested capital | -36.8% | — | +22.8% | — | -2.2% |
| ROCEReturn on capital employed | -22.7% | +3.8% | +6.9% | -25.3% | -1.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.34x | 0.51x | 0.12x | 0.44x | 1.39x |
| Net DebtTotal debt minus cash | -$203M | -$489M | -$198M | -$2.3B | $46M |
| Cash & Equiv.Liquid assets | $385M | $690M | $250M | $2.8B | $314M |
| Total DebtShort + long-term debt | $182M | $201M | $52M | $430M | $360M |
| Interest CoverageEBIT ÷ Interest expense | — | 1.86x | — | -0.57x | — |
Total Returns (Dividends Reinvested)
Evenly matched — LMND and ROOT and OSCR each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OSCR five years ago would be worth $9,271 today (with dividends reinvested), compared to $1,105 for HIPO. Over the past 12 months, LMND leads with a +78.2% total return vs VERX's -60.8%. The 3-year compound annual growth rate (CAGR) favors ROOT at 117.4% vs VERX's -10.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -28.3% | -19.7% | -8.5% | +39.4% | -22.8% |
| 1-Year ReturnPast 12 months | +78.2% | -59.3% | +12.2% | +22.6% | -60.8% |
| 3-Year ReturnCumulative with dividends | +234.7% | +927.3% | +48.3% | +177.5% | -28.6% |
| 5-Year ReturnCumulative with dividends | -31.2% | -69.6% | -88.9% | -7.3% | -15.6% |
| 10-Year ReturnCumulative with dividends | -21.6% | -88.3% | -90.5% | -40.0% | -38.7% |
| CAGR (3Y)Annualised 3-year return | +49.6% | +117.4% | +14.0% | +40.5% | -10.6% |
Risk & Volatility
Evenly matched — OSCR and VERX each lead in 1 of 2 comparable metrics.
Risk & Volatility
VERX is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than LMND's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OSCR currently trades 87.7% from its 52-week high vs VERX's 34.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.75x | 2.30x | 1.40x | 1.84x | 0.83x |
| 52-Week HighHighest price in past year | $99.90 | $162.99 | $38.98 | $23.80 | $42.44 |
| 52-Week LowLowest price in past year | $28.71 | $40.91 | $19.92 | $10.69 | $10.59 |
| % of 52W HighCurrent price vs 52-week peak | +54.5% | +34.9% | +70.4% | +87.7% | +34.6% |
| RSI (14)Momentum oscillator 0–100 | 36.3 | 56.6 | 48.9 | 78.5 | 50.3 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 330K | 110K | 6.5M | 1.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: LMND as "Buy", ROOT as "Hold", HIPO as "Buy", OSCR as "Hold", VERX as "Buy". Consensus price targets imply 41.9% upside for VERX (target: $21) vs -19.7% for OSCR (target: $17).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $72.67 | $75.00 | $28.38 | $16.75 | $20.82 |
| # AnalystsCovering analysts | 15 | 14 | 6 | 11 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +2.0% | 0.0% | +0.4% |
ROOT leads in 1 of 6 categories (Valuation Metrics). HIPO leads in 1 (Profitability & Efficiency). 3 tied.
LMND vs ROOT vs HIPO vs OSCR vs VERX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LMND or ROOT or HIPO or OSCR or VERX a better buy right now?
For growth investors, Lemonade, Inc.
(LMND) is the stronger pick with 40. 2% revenue growth year-over-year, versus 12. 2% for Vertex, Inc. (VERX). Hippo Holdings Inc. (HIPO) offers the better valuation at 12. 4x trailing P/E (114. 3x forward), making it the more compelling value choice. Analysts rate Lemonade, Inc. (LMND) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LMND or ROOT or HIPO or OSCR or VERX?
On trailing P/E, Hippo Holdings Inc.
(HIPO) is the cheapest at 12. 4x versus Vertex, Inc. at 366. 8x. On forward P/E, Vertex, Inc. is actually cheaper at 19. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — LMND or ROOT or HIPO or OSCR or VERX?
Over the past 5 years, Oscar Health, Inc.
(OSCR) delivered a total return of -7. 3%, compared to -88. 9% for Hippo Holdings Inc. (HIPO). Over 10 years, the gap is even starker: LMND returned -21. 6% versus HIPO's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LMND or ROOT or HIPO or OSCR or VERX?
By beta (market sensitivity over 5 years), Vertex, Inc.
(VERX) is the lower-risk stock at 0. 83β versus Lemonade, Inc. 's 2. 75β — meaning LMND is approximately 234% more volatile than VERX relative to the S&P 500. On balance sheet safety, Hippo Holdings Inc. (HIPO) carries a lower debt/equity ratio of 12% versus 139% for Vertex, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — LMND or ROOT or HIPO or OSCR or VERX?
By revenue growth (latest reported year), Lemonade, Inc.
(LMND) is pulling ahead at 40. 2% versus 12. 2% for Vertex, Inc. (VERX). On earnings-per-share growth, the picture is similar: Hippo Holdings Inc. grew EPS 235. 4% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, ROOT leads at 69. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LMND or ROOT or HIPO or OSCR or VERX?
Hippo Holdings Inc.
(HIPO) is the more profitable company, earning 12. 3% net margin versus -22. 4% for Lemonade, Inc. — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIPO leads at 13. 5% versus -21. 8% for LMND. At the gross margin level — before operating expenses — VERX leads at 60. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LMND or ROOT or HIPO or OSCR or VERX more undervalued right now?
On forward earnings alone, Vertex, Inc.
(VERX) trades at 19. 9x forward P/E versus 114. 3x for Hippo Holdings Inc. — 94. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VERX: 41. 9% to $20. 82.
08Which pays a better dividend — LMND or ROOT or HIPO or OSCR or VERX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is LMND or ROOT or HIPO or OSCR or VERX better for a retirement portfolio?
For long-horizon retirement investors, Vertex, Inc.
(VERX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 83)). Root, Inc. (ROOT) carries a higher beta of 2. 30 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VERX: -38. 7%, ROOT: -88. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LMND and ROOT and HIPO and OSCR and VERX?
These companies operate in different sectors (LMND (Financial Services) and ROOT (Financial Services) and HIPO (Financial Services) and OSCR (Healthcare) and VERX (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LMND is a small-cap high-growth stock; ROOT is a small-cap high-growth stock; HIPO is a small-cap high-growth stock; OSCR is a small-cap high-growth stock; VERX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.